| RS2082049708 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2082051355 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2082051467 |
COQ8B
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 9 |
| RS2082052550 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS2082057042 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2082061881 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 2A |
| RS2082083331 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2082084610 |
TTN
|
Health Risk |
Likely pathogenic |
TTN-related disorder, Dilated cardiomyopathy 1G |
| RS2082085635 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2082092886 |
COQ8B
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 9 |
| RS2082112216 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2082115419 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082120435 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082124375 |
ANK3
|
Health Risk |
Pathogenic |
— |
| RS2082128828 |
STAT3
|
Health Risk |
Pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2082153181 |
KARS1
|
Health Risk |
Pathogenic |
LEUKOENCEPHALOPATHY, PROGRESSIVE |
| RS2082158844 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2082170216 |
COQ8B
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 9 |
| RS2082179831 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2082180462 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 2A |
| RS2082191056 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082192813 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2082207948 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082208014 |
KARS1
|
Health Risk |
Pathogenic |
— |
| RS2082208208 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082209411 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082212783 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2082227467 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082232988 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2082233410 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2082233689 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, KCNQ2-related disorder |
| RS2082233766 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082235501 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2082240394 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2082253437 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2082253736 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS2082254429 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2082258116 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2082260036 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2082260996 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2082272257 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082272406 |
SPG11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Hereditary spastic paraplegia 11 |
| RS2082273335 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082282118 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082297073 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082298022 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082301397 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082302853 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082303743 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082304563 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082305146 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082305577 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2082307406 |
ARMC5
|
Health Risk |
Pathogenic |
— |
| RS2082308153 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082308925 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2082309297 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Gastric cancer |
| RS2082310429 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2082322839 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2082328931 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082333064 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082338123 |
ARMC5
|
Health Risk |
Likely pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS2082348062 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2082362479 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, Intellectual disability |
| RS2082366378 |
EEF1A2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2082366618 |
EEF1A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2082373823 |
ANK3
|
Health Risk |
Pathogenic |
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome, Intellectual disability-hypotonia-spasticity-sleep disorder syndrome |
| RS2082374257 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082374687 |
SPG11
|
Health Risk |
Likely pathogenic |
See cases, Hereditary spastic paraplegia 11 |
| RS2082375273 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2082375533 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082381612 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082382004 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082382534 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082383767 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082385904 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082389962 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082390512 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082400132 |
TMEM126B
|
Health Risk |
Pathogenic |
— |
| RS2082401685 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082406987 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2082409766 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS2082414008 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS2082414178 |
EEF1A2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2082414661 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2082415487 |
TPK1
|
Health Risk |
Likely pathogenic |
— |
| RS2082424804 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, Developmental and epileptic encephalopathy |
| RS2082424831 |
EEF1A2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2082439915 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Hepatocellular carcinoma |
| RS2082448894 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082449528 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2082450607 |
SPG11
|
Health Risk |
Pathogenic |
— |
| RS2082452692 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082452725 |
MYH10
|
Health Risk |
Likely pathogenic |
— |
| RS2082470151 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS2082478614 |
TTN
|
Health Risk |
Likely pathogenic |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS2082503070 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS2082517369 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2082518811 |
ABCD4
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS2082520628 |
TMEM126A
|
Health Risk |
Pathogenic |
— |
| RS2082522248 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Hereditary cancer-predisposing syndrome |